Artificial intelligence enhances screening efficiency for inflammatory bowel disease clinical trials: a prospective study

Inflammatory Bowel Diseases 2026

View at publisher
Authors: Akshita Gupta, Ryan C. Ungaro, Adam F. Steinlauf, Jean-Frederic Colombel, Sari Feldman, Asher Leviton, Alberta Onyuka, Phyu Mar, Michele Cohen, Robert Freeman, Girish N Nadkarni, Eyal Klang
DOI: 10.1093/ibd/izag021
Cited by: 2
References: 10

Abstract

An LLM-based AI tool significantly improved identification of potentially eligible patients and screening efficiency for IBD clinical trials, outperforming physician referrals by screening electronic medical records and generating ranked candidate lists based on trial inclusion/exclusion criteria, thereby enhancing trial recruitment.

Fields of Study & Subjects

Artificial Intelligence in Healthcare and Education Inflammatory Bowel Disease AI in cancer detection

Publication details

Journal / source
Inflammatory Bowel Diseases
Publisher
Oxford University Press (OUP)
Volume
32
Issue
8
Pages
1640–1643
Publication date
2 February 2026
Language
EN